$157.18
2.07%
Nasdaq, Oct 01, 04:00 pm EDT. Closed.

ICU Medical, Inc. Target price 2026 - Analyst rating & recommendation

ICU Medical, Inc. Classifications & Recommendation

Buy
92%
Hold
8%

ICU Medical, Inc. Price Target

Target Price $198.90
Price $157.18
Potential
Number of Estimates 9
9 Analysts have issued a price target ICU Medical, Inc. 2027 . The average ICU Medical, Inc. target price is $198.90. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 13 analysts: 12 Analysts recommend ICU Medical, Inc. to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the ICU Medical, Inc. stock has an average upside potential 2027 of . Most analysts recommend the ICU Medical, Inc. stock at Purchase.

Sales and Margin forecast 2026, 2027 to 2030

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Revenue Billion $ 2.23 2.24
6.33% 0.17%
EBITDA Margin 4.99% 19.39%
14.26% 288.82%
Net Margin 0.03% 9.99%
100.66% 30,434.64%

10 Analysts have issued a sales forecast ICU Medical, Inc. 2026 . The average ICU Medical, Inc. sales estimate is

$2.2b
unlock
. This is
3.49% higher
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$2.3b 7.71%
unlock
, the lowest is
$2.1b 1.14%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 $2.2b 6.33%
2026
$2.2b 0.17%
unlock
2027
$2.3b 4.43%
unlock
2028
$2.4b 4.76%
unlock
2029
$2.7b 9.69%
unlock
2030
$2.8b 5.59%
unlock

10 Analysts have issued an ICU Medical, Inc. EBITDA forecast 2026. The average ICU Medical, Inc. EBITDA estimate is

$433m
unlock
. This is
196.54% higher
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$449m 207.49%
unlock
, the lowest is
$414m 182.97%
unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 $111m 7.03%
2026
$433m 289.49%
unlock
2027
$470m 8.49%
unlock
2028
$498m 5.97%
unlock
2029
$563m 13.01%
unlock
2030
$608m 7.97%
unlock

EBITDA Margin

2025 4.99% 14.26%
2026
19.39% 288.82%
unlock
2027
20.14% 3.87%
unlock
2028
20.38% 1.19%
unlock
2029
20.99% 2.99%
unlock
2030
21.47% 2.29%
unlock

10 ICU Medical, Inc. Analysts have issued a net profit forecast 2026. The average ICU Medical, Inc. net profit estimate is

$223m
unlock
. This is
642.04% higher
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$232m 670.62%
unlock
, the lowest is
$212m 603.76%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 $730k 100.62%
2026
$223m 30,486.30%
unlock
2027
$246m 10.21%
unlock
2028
$264m 7.45%
unlock
2029
$305m 15.29%
unlock
2030
$338m 10.88%
unlock

Net Margin

2025 0.03% 100.66%
2026
9.99% 30,434.64%
unlock
2027
10.54% 5.51%
unlock
2028
10.81% 2.56%
unlock
2029
11.37% 5.18%
unlock
2030
11.94% 5.01%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2030

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Earnings Per Share $ 0.03 8.93
100.62% 29,666.67%
P/E 17.98
EV/Sales 2.22

10 Analysts have issued a ICU Medical, Inc. forecast for earnings per share. The average ICU Medical, Inc. EPS is

$8.93
unlock
. This is
656.78% higher
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
$9.27 685.59%
unlock
, the lowest is
$8.47 617.80%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 $0.03 100.62%
2026
$8.93 29,666.67%
unlock
2027
$9.84 10.19%
unlock
2028
$10.57 7.42%
unlock
2029
$12.19 15.33%
unlock
2030
$13.52 10.91%
unlock

P/E ratio

Current 136.03 270.59%
2026
17.98 86.78%
unlock
2027
16.31 9.29%
unlock
2028
15.18 6.93%
unlock
2029
13.17 13.24%
unlock
2030
11.88 9.79%
unlock

Based on analysts' sales estimates for 2026, the ICU Medical, Inc. stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 2.29 36.31%
2026
2.22 3.23%
unlock
2027
2.12 4.24%
unlock
2028
2.03 4.54%
unlock
2029
1.85 8.84%
unlock
2030
1.75 5.30%
unlock

P/S ratio

Current 1.86 50.35%
2026
1.80 3.37%
unlock
2027
1.72 4.24%
unlock
2028
1.64 4.54%
unlock
2029
1.50 8.84%
unlock
2030
1.42 5.30%
unlock

Current ICU Medical, Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
BTIG
Locked
➜
Locked
Locked Aug 07 2026
Piper Sandler
Locked
➜
Locked
Locked Aug 07 2026
Needham
Locked
➜
Locked
Locked Aug 07 2026
Keybanc
Locked
➜
Locked
Locked Jul 21 2026
BTIG
Locked
➜
Locked
Locked Jun 15 2026
Needham
Locked
➜
Locked
Locked May 27 2026
Keybanc
Locked
➜
Locked
Locked Apr 27 2026
Analyst Rating Date
Locked
BTIG:
Locked
➜
Locked
Aug 07 2026
Locked
Piper Sandler:
Locked
➜
Locked
Aug 07 2026
Locked
Needham:
Locked
➜
Locked
Aug 07 2026
Locked
Keybanc:
Locked
➜
Locked
Jul 21 2026
Locked
BTIG:
Locked
➜
Locked
Jun 15 2026
Locked
Needham:
Locked
➜
Locked
May 27 2026
Locked
Keybanc:
Locked
➜
Locked
Apr 27 2026

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today